Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Chordate Medical Holding: BioStock: Chordate Medical's CEO on the rights issue outcome and way forward

Chordate Medical Holding

Chordate Medical has now announced the outcome of the rights issue that was completed on February 17. The issue was subscribed to approximately 79.9 per cent in total, of which around 18.4 per cent by guarantee commitments. This means that the company will receive approximately SEK 17.7 million before deduction of issue costs. 

Read the full article at biostock.se:

https://www.biostock.se/en/2025/02/chordate-medicals-ceo-on-the-rights-issue-outcome-and-way-forward/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.